// App-Quantinova.ai

2064 : Inhibition of NADPH Oxidase in Phagocytes Improves Hepatic Steatosis, Inflammation and Fibrosis in a Mouse Model of Severe Nonalcoholic Steatohepatitis (NASH)

Researchers

Presenter

  • Lucy M. Golden-Mason

Principal Investigators

  • Rachel McMahan

  • Eric L. Campbell

  • Linling Cheng

  • David J. Orlicky

  • Hugo R. Rosen

Medical Centers

  • University of Colorado Cancer Center, Aurora, CO

  • Centre for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom

  • University of Colorado Cancer Center, Aurora, CO

  • Veterans Affairs Medical Center, Denver, CO

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Nonalcoholic steatohepatitis

  • Fatty Liver Disease

Biomarkers

  • Nicotinamide adenine dinucleotide phosphate oxidase

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A